Appili Therapeutics Inc. (TSX: APLI)
Canada
· Delayed Price · Currency is CAD 0.0400
0.00 (0.00%)
Jul 2, 2024, 2:20 PM EDT
Appili Therapeutics Market Cap
Appili Therapeutics has a market cap or net worth of 4.85 million as of July 2, 2024.
Market Cap
4.85M
Enterprise Value
12.94M
Revenue
827.41K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since March 31, 2018, Appili Therapeutics's market cap has decreased from 26.83M to 4.85M, a decrease of -81.92%. That is a compound annual growth rate of -23.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 4.85M | 14.29% |
| Mar 31, 2024 | 4.24M | -6.70% |
| Mar 31, 2023 | 4.55M | -43.19% |
| Mar 31, 2022 | 8.01M | -87.81% |
| Mar 31, 2021 | 65.69M | 181.42% |
| Mar 31, 2020 | 23.34M | -3.55% |
| Mar 31, 2019 | 24.20M | -9.80% |
| Mar 31, 2018 | 26.83M | 67.23% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 6.95B |
| Bausch Health Companies Inc. | 3.50B |
| Tilray Brands, Inc. | 1.87B |
| WELL Health Technologies Corp. | 1.16B |
| Sienna Senior Living Inc. | 1.04B |
| Canopy Growth Corporation | 673.59M |
| Extendicare Inc. | 603.70M |
| Knight Therapeutics Inc. | 574.80M |